COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study

BACKGROUND: The rate of seroconversion after COVID-19 vaccination in patients with moderate to severe psoriasis requiring systemic treatment is poorly understood. OBJECTIVES: The aim of this prospective single-center cohort study performed between May 2020 and October 2021 was to determine the rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodde, Georg Christian, Krefting, Frederik, Placke, Jan-Malte, Schneider, Lea, Fiedler, Melanie, Dittmer, Ulf, Becker, Jürgen Christian, Hölsken, Stefanie, Schadendorf, Dirk, Ugurel, Selma, Sondermann, Wiebke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061348/
https://www.ncbi.nlm.nih.gov/pubmed/37006279
http://dx.doi.org/10.3389/fimmu.2023.1107438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061348/
https://www.ncbi.nlm.nih.gov/pubmed/37006279
http://dx.doi.org/10.3389/fimmu.2023.1107438

Ejemplares similares